Prognostic factors and clinical features in liveborn neonates with hydrops fetalis

被引:52
作者
Huang, Hsuan-Rong
Tsay, Pei-Kwei
Chiang, Ming-Chou
Lien, Reyin
Chou, Yi-Hung
机构
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat,Div Neonatol, Tao Yuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Dept Publ Hlth, Tao Yuan 333, Taiwan
[3] Chang Gung Univ, Coll Med, Ctr Biostat, Tao Yuan 333, Taiwan
关键词
albumin; hydrops fetalis; lymphatic malformations; neonates; outcome;
D O I
10.1055/s-2006-958158
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The purpose of this study was to delineate the etiology and the clinical features of liveborn neonates with hydrops fetalis, and to explore the prognostic factors for survival. Medical records of 28 liveborn neonates with hydrops fetalis between April 1995 and March 2005 were reviewed retrospectively. Demographic data, clinical manifestations, laboratory findings, and outcomes were analyzed. Most patients presented with pleural effusions (21 of 28) and ascites (22 of 28). The majority of patients had hydrops due to cardiovascular diseases (seven of 28), hematologic disorders (six of 28), lymphatic malformations (six of 28), and idiopathic origins (six of 28). The overall survival rate was 50% and was highest (83%) in infants with lymphatic malformations. By univariate analysis, risk factors for mortality are earlier ages at diagnosis and at birth, low Apgar scores, need for resuscitation in the delivery room, low serum albumin level, and severe acidemia. After using stepwise multiple logistic regression analysis, the most significant factors associated with fatality were younger gestational age at birth and lower serum albumin level. Hydrops fetalis remains a complex condition with a high mortality rate. Hydrops resulting from lymphatic malformations has a favorable outcome. Preterm birth at less than 34 weeks and serum albumin concentration lower than 2 g/dL are two poor prognostic factors for survival.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 27 条
[1]   CHROMOSOMAL-ANOMALIES IN FETAL CONGENITAL HEART-DISEASE [J].
ALLAN, LD ;
SHARLAND, GK ;
CHITA, SK ;
LOCKHART, S ;
MAXWELL, DJ .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1991, 1 (01) :8-11
[2]   Primary pulmonary lymphangiectasia in infancy and childhood [J].
Barker, PM ;
Esther, CR ;
Fordham, LA ;
Maygarden, SJ ;
Funkhouser, W .
EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (03) :413-419
[3]   Anti-M isoimmunization: Management and outcome at The Ohio State University from 1969 to 1995 [J].
DeYoungOwens, A ;
Kennedy, M ;
Rose, RL ;
Boyle, J ;
OShaughnessy, R .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (06) :962-966
[4]   Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome [J].
Faul, JL ;
Berry, GJ ;
Colby, TV ;
Ruoss, SJ ;
Walter, MB ;
Rosen, GD ;
Raffin, TA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :1037-1046
[5]  
Forouzan I, 1997, Obstet Gynecol Surv, V52, P130, DOI 10.1097/00006254-199702000-00022
[6]   Prenatal diagnosis of intrahepatic communications of the umbilical vein with atypical arteries (A-V fistulae) in two cases of trisomy 21 using color Doppler ultrasound [J].
Hartung, J ;
Chaoui, R ;
Kalache, K ;
Tennstedt, C ;
Bollmann, R .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 16 (03) :271-274
[7]   Etiology and outcome of second trimester non-immunologic fetal hydrops [J].
Heinonen, S ;
Ryynänen, M ;
Kirkinen, P .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (01) :15-18
[8]   Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy [J].
Iskaros, J ;
Jauniaux, E ;
Rodeck, C .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (03) :321-325
[9]  
Jauniaux E, 1997, PRENATAL DIAG, V17, P1261, DOI 10.1002/(SICI)1097-0223(199712)17:13<1261::AID-PD292>3.0.CO
[10]  
2-C